Study Shows Clinical Benefit With Once Weekly Semaglutide in Patients With Obesity

By epicouncil | Obesity | Comments are Closed | 7 May, 2021 | 0

Reference

Wilding JP, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine; February 10, 2021. Accessed February 18, 2021. doi: 10.1056/NEJMoa2032183.

A recent study published in The New England Journal of Medicine reported that treatment with once weekly semaglutide, along with lifestyle intervention, in individuals who are overweight or obese resulted in sustained and clinically beneficial weight loss.

Obesity is a chronic disease that can lead to insulin resistance, hypertension, and dyslipidemia and is associated with type 2 diabetes and cardiovascular disease (CVD), among other conditions. Despite the prevalence of obesity worldwide, there remain few drugs indicated for the disease.

Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue currently approved to treat type 2 diabetes and to reduce the risk of cardiovascular events in individuals with type 2 diabetes and CVD.

Read the full article on Drug Topics here: https://www.drugtopics.com/view/study-shows-clinical-benefit-with-once-weekly-semaglutide-in-patients-with-obesity

Please note: This article was published by Drug Topics and is not affiliated with Employer-Provider Interface Council (EPIC). The above link is provided as a suggested reading we believe valuable to EPIC users.

No tags.

epicouncil

More posts by epicouncil

COVID-19, Obesity, and the Path Forward for Employers

By epicouncil | Comments are Closed

Harber ML. COVID-19, Obesity, and the Path Forward for Employers. HRProfessionalsMagazine. https://hrprofessionalsmagazine.com/2021/06/29/covid-19-obesity-and-the-path-forward-for-employers/. Published June 29, 2021. We have explored over the past few issues the needs of employers to offer a comprehensive approach toRead more
Obesity is a Critically Important Health Issue

By epicouncil | Comments are Closed

Harber ML. Obesity is a Critically Important Health Issue. HRProfessionalsMagazine. https://hrprofessionalsmagazine.com/2021/03/30/obesity-is-a-critically-important-health-issue/. Published March 3, 2021. Obesity can affect a person’s overall health and daily performance in negative ways by adding more health risks thatRead more
Nearly a decade on – trends, risk factors and policy implications in global obesity

By epicouncil | Comments are Closed

Malik, V.S., Willet, W.C. & Hu, F.B. Nearly a decade on — trends, risk factors and policy implications in global obesity. Nat Rev Endocrinol 16, 615–616 (2020). https://doi.org/10.1038/s41574-020-00411-y In the past decade, the prevalence of obesity andRead more
Behavior-based diabetes management: impact on care, hospitalizations, and costs

By epicouncil | Comments are Closed

Ahern DK, Aberger EW, Wroblewski JP, et al. Behavior-based diabetes management: impact on care, hospitalizations, and costs. The American Journal of Managed Care. 2021 Mar;27(3):96-102. DOI: 10.37765/ajmc.2021.88597. This study evaluated a commercially available diabetesRead more
The Health Risks of Obesity Worse Than Smoking, Drinking or Poverty

By epicouncil | Comments are Closed

Sturm, Roland and Kenneth B. Wells, The Health Risks of Obesity: Worse Than Smoking, Drinking or Poverty. Santa Monica, CA: RAND Corporation, 2002. https://www.rand.org/pubs/research_briefs/RB4549.html. Obesity is widely recognized as a health risk. The negativeRead more